Jonathan Hirsch is the Chief Strategy and Growth Officer at Paradigm, a company rebuilding the clinical research ecosystem by creating a platform that enables equitable access to trials for all patients while enhancing trial efficiency and reducing the barriers to participation for healthcare providers. Jonathan's investments include Axle Health, Verifiable, Daybreak Health, OccamzRazor, and Osmind.